Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HSD3B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CAB39L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELAVL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCTD15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HBG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PSMB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARP4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALYREF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAP1L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FEZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM3AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927884 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KREMEN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728283 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on